Free Trial
NASDAQ:BEATW

HeartBeam Earnings Date & Estimates

HeartBeam logo
$0.0060 0.00 (-14.35%)
As of 12:40 PM Eastern
This is a fair market value price provided by Massive. Learn more.

HeartBeam is estimated to report earnings on Thursday, November 12, 2026, after market closes.

Upcoming Earnings Announcement

Announcement Date
Time
After Market Closes

What Analysts Expect from HeartBeam

HeartBeam is expected to post earnings of -$0.09 per share on revenue of $80 thousand.

Consensus Estimates

Consensus EPS
-$0.09
Expected Revenue
$80 thousand

Prepare for the Earnings Call

HeartBeam Earnings FAQ

HeartBeam (NASDAQ:BEATW) is estimated to report earnings on Thursday, November 12, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect HeartBeam to post earnings of -$0.09 per share for the quarter.

The consensus revenue estimate for HeartBeam is $80 thousand for the quarter.

HeartBeam Earnings Headlines

HeartBeam Appoints CEO Robert Eno to Board
A free stock pick, from me to you
Elon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.tc pixel
See More HeartBeam Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like HeartBeam? Sign up for Earnings360's daily newsletter to receive timely earnings updates on HeartBeam and other key companies, straight to your email.

About HeartBeam

HeartBeam (NASDAQ:BEATW) is a medical technology company developing portable tools for cardiac assessment and monitoring. Its technology is designed to capture electrocardiogram (ECG) signals outside traditional clinical settings, supporting more convenient evaluation of heart activity.

The company’s platform records electrical signals from three distinct directions and uses software to generate a synthesized 12-lead ECG for clinician review. HeartBeam is also developing digital health and remote-monitoring capabilities intended to help clinicians assess patients beyond the hospital or clinic.

HeartBeam is based in the United States and focuses on bringing cardiac diagnostic technology into more accessible settings. Its products are intended to complement, not replace, evaluation by qualified healthcare professionals.

View HeartBeam Profile